Ketamine as an Alternative Treatment to ECT in Major Depressive Disorder
NCT02659085 · Status: COMPLETED · Phase: PHASE2/PHASE3 · Type: INTERVENTIONAL · Enrollment: 198
Last updated 2019-12-19
Summary
Developing more effective and faster acting antidepressant is of outmost clinical importance. Available antidepressant therapies have a delayed therapeutic effect. It typically takes several weeks before symptom relief is evident. Furthermore, antidepressants are relatively ineffective - as many as 30% of patients do not respond to any medication at all. In this study the investigators evaluate the NMDA-receptor antagonist ketamine as a potentially new antidepressant treatment for severely depressed patients and compare its effectiveness with that of electroconvulsive therapy (ECT).
Conditions
- Depressive Disorder, Major
Interventions
- DRUG
-
Ketamine IV Infusion
Patients randomized to the experimental treatment receive intravenous infusions of racemic ketamine (0.5 mg/kg), delivered over a period of forty minutes thrice weekly (Monday, Wednesday, Friday) under supervision.
- PROCEDURE
-
ECT
ECT given in line with standard procedures (including anesthesia, muscle relaxation and oxygenation) thrice weekly.
Sponsors & Collaborators
-
Pouya Movahed Rad
lead OTHER
Principal Investigators
-
Pouya Movahed Rad, MD, PhD · Dept of Clinical Sciences Lund, Faculty of Medicine Lund University, Sweden
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 85 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2015-02-28
- Primary Completion
- 2019-08-31
- Completion
- 2019-08-31
Countries
- Sweden
Study Locations
More Related Trials
-
Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression
NCT02522377 ·Status: COMPLETED ·Phase: NA
-
ELEKT-D: Electroconvulsive Therapy (ECT) vs. Ketamine in Patients With Treatment Resistant Depression (TRD)
NCT03113968 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Ketamine Versus Electroconvulsive Therapy in Depression
NCT03674671 ·Status: SUSPENDED ·Phase: PHASE3
-
Ketamine Infusion for Adolescent Depression and Anxiety
NCT02579928 ·Status: COMPLETED ·Phase: PHASE4
-
Ketamine as a Rapidly-Acting Antidepressant in Depressed Emergency Department Patients
NCT02106325 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine Infusions for Major Depression Disorder
NCT02219867 ·Status: UNKNOWN ·Phase: NA
-
Clinical Trial of the Use of Ketamine in Treatment Resistant Depression
NCT02610712 ·Status: UNKNOWN ·Phase: PHASE4
-
Efficacy of Repeated Ketamine Infusions for Treatment-resistant Depression
NCT02360280 ·Status: COMPLETED ·Phase: PHASE2
-
Optimization of IV Ketamine for Treatment Resistant Depression
NCT00768430 ·Status: COMPLETED ·Phase: PHASE2
-
IV Ketamine Vs. in Esketamine for MDD TRD
NCT06488586 ·Status: RECRUITING
-
Ketamine Augmentation of ECT in Treatment-Resistant Depression
NCT07088380 ·Status: RECRUITING ·Phase: PHASE3
-
Continuation Ketamine in Major Depression
NCT00548964 ·Status: COMPLETED ·Phase: PHASE1
-
Continuation Electroconvulsive Therapy Vs Medication to Prevent Relapses in Patients With Major Depressive Disorder
NCT00000375 ·Status: COMPLETED ·Phase: PHASE4
-
Rapid Antidepressant Effects of Ketamine in Major Depression
NCT00088699 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Ketamine for Major Depressive Disorder
NCT03721900 ·Status: UNKNOWN ·Phase: PHASE1
-
Ketamine Interleaved With Electroconvulsive Therapy for Depression
NCT04082858 ·Status: TERMINATED ·Phase: PHASE1
-
Neuropharmacologic Imaging and Biomarker Assessments of Response to Acute and Repeated-Dosed Ketamine Infusions in Major Depressive Disorder
NCT03065335 ·Status: RECRUITING ·Phase: PHASE1
-
Ketamine for Severe Adolescent Depression: Intermediate-term Safety and Efficacy
NCT03889756 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Ketamine Plus Lithium in Treatment-Resistant Depression
NCT01880593 ·Status: COMPLETED ·Phase: PHASE2
-
Ketamine and Scopolamine Infusions for Treatment-resistant Major Depressive Disorder
NCT01613820 ·Status: WITHDRAWN ·Phase: NA
-
Ketamine for Treatment Resistant Late-Life Depression
NCT02556606 ·Status: COMPLETED ·Phase: PHASE3
-
Biomarkers of Fast Acting Therapies in Major Depression
NCT02165449 ·Status: COMPLETED ·Phase: PHASE1
-
Predictors of Intravenous Ketamine Response in TRD
NCT05625555 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Nebulized Ketamine for the Treatment of Major Depressive Disorder
NCT06752759 ·Status: RECRUITING ·Phase: PHASE3
-
Ketamine in the Treatment of Depression
NCT01558063 ·Status: COMPLETED ·Phase: PHASE2